Expression in insect cells of the functional domain of CD21 (complement receptor type two) as a truncated soluble molecule using a baculovirus vector

Immunopharmacology

Volumn 38, Issue 1-2, 1997, Pages 141-148

  Prodinger, Wolfgang M ^a   Schoch, Jürgen ^a   Schwendinger, Michael G ^a   Hellwage, Jens ^b   Parson, Walther ^a   Zipfel, Peter F ^b   Dierich, Manfred P ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

CD21; Complement; Monoclonal antibody; Receptor; Recombinant baculovirus

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ARTICLE; B LYMPHOCYTE; BACULOVIRUS; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INSECT; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; B-LYMPHOCYTES; BACULOVIRIDAE; FEMALE; GENETIC VECTORS; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; PLASMIDS; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3D; RECOMBINANT PROTEINS; SPODOPTERA;

EID: 0031474955     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00062-3     Document Type: Article

References (20)

1. Aubry, J.P., Pochon, S., Gauchat, J.F., 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J. Immunol. 152, 5806-5813.
2. Bohnsack, J.F., Cooper, N.R., 1988. CR2 ligands modulate human B cell activation. J. Immunol. 141, 2569-2576.
3. Carel, J.C., Frazier, B., Ley, T.J., Holers, V.M., 1989. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells. J. Immunol. 143, 923-930.
4. Carel, J.C., Myones, B.L., Frazier, B., Holers, V.M., 1990. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J. Biol. Chem. 265, 12293-12299.
5. Davies, A., Morgan, B.P., 1993. Expression of the glycosylphosphatidylinositol-linked complement-inhibiting protein CD59 antigen in insect cells using a baculovirus vector. Biochem. J. 295, 889-896.
6. Fearon, D.T., Carter, R.H., 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity. Annu. Rev. Immunol. 13, 127-149.
7. Fischer, E., Delibrias, C., Kazatchkine, M.D., 1991. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146, 865-869.
8. Hebell, T., Ahearn, J.M., Fearon, D.T., 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254, 102-105.
9. Kühn, S., Skerka, C., Zipfel, P.F., 1995. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H. J Immunol. 155, 5663-5670.
10. Kühn, S., Zipfel, P.F., 1995. The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. Gene 162, 225-229.
11. Liu, Y.J., Xu, J.C., Debouteiller, O., 1997. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J. Exp. Med. 185, 165-170.
12. Matsumoto, A.K., Kopicky Burd, J., Carter, R.H., Tuveson, D.A., Tedder, T.F., Fearon, D.T., 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173, 55-64.
13. Melchers, F., Erdei, A., Schulz, T., Dierich, M.P., 1985. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature 317, 264-267.
14. Moore, M.D., Cannon, M.J., Sewall, A., Finlayson, M., Okimoto, M., Nemerow, G.R., 1991. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21 ) containing two short consensus repeats. J. Virol. 65, 3559-3565.
15. Nemerow, G.R., Mullen, J.J., Dickson, P.W., Cooper, N.R., 1990. Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection. J. Virol. 64, 1348-1352.
16. Petzer, A.L., Schulz, T.F., Stauder, R., Eigentler, A., Myones, B.L., Dierich, M.P., 1988. Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion. Immunology 63, 47-53.
17. Prodinger, W.M., Larcher, C., Schwendinger, M., Dierich, M.P., 1996. Ligation of the functional domain of complement receptor type 2 (CR2. CD21) is relevant for complex formation in T cell lines. J. Immunol. 156, 2580-2584.
18. Schwendinger, M.G., Spruth, M., Schoch, J., Dierich, M.P., Prodinger, W.M., 1997. A novel mechanism of alternative pathway complement activation accounts for the deposition of C3-fragments on CR2-expressing homologous cells. J. Immunol. 158, 5455-5464.
19. Tedder, T.F., Clement, L.T., Cooper, M.D., 1984. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133, 678-683.
20. Vik, D.P., Fearon, D.T., 1985. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3. J. Immunol. 134, 2571-2579.